The CD11b Antibody is a highly specific and sensitive reagent designed to detect CD11b, also known as integrin alpha M (ITGAM), a crucial surface marker expressed predominantly on myeloid cells including monocytes, macrophages, granulocytes, and natural killer cells. CD11b plays an essential role in immune response regulation, cell adhesion, migration, and phagocytosis, making it a key target for research in immunology, inflammation, and cancer. This antibody is widely used for identifying and characterizing activated myeloid cells in both normal and diseased tissues. Our CD11b antibody is validated for multiple applications, including flow cytometry, immunohistochemistry (IHC), immunofluorescence (IF), and Western blotting, providing researchers with reliable and reproducible results. Optimized for low background and strong signal intensity, this CD11b antibody is ideal for detailed immune profiling, mechanistic studies, and therapeutic research. Whether investigating the role of macrophages in chronic inflammatory diseases, analyzing immune cell infiltration in tumors, or studying leukocyte adhesion and migration, this antibody supports advanced research needs with consistent performance.
RM290
RM290 reacts to human CD11b (Integrin alpha-M)
A peptide corresponding to the C-terminus of human CD11b (Integrin alpha-M)
Immunohistochemistry (IHC) Western Blot (WB)
Human
None
Research Use Only
Stable for 1 Year at -20.0°C from date of receipt.